HCG (Human Chorionic Gonadotropin)

HCG is one of the most misunderstood compounds in the fitness and weight-loss worlds, mostly because people keep talking about it as if it were a steroid or a “peptide” performance drug. It is really neither. It is a glycoprotein hormone — a gonadotropin (a hormone that signals the sex glands) — and it works by imitating luteinizing hormone, the body’s own signal that tells the gonads (testes or ovaries) to make more of their own sex hormones. That one difference explains everything: how it works, what it is actually good for, and where the marketing around it goes off the rails.

What it is

HCG is a glycoprotein hormone, not a steroid. The usual steroid labels — things like “androgen receptor agonist,” “17-alpha-alkylated oral,” or “injectable ester” — simply do not apply to it. Those belong to anabolic-androgenic steroids (AAS, the muscle-building family of steroids). HCG has no pill form and no ester chemistry. It is a glycoprotein given by injection — either intramuscular (into the muscle) or subcutaneous (under the skin) — because your gut would digest it if you swallowed it.

Structurally, it is built from two pieces that fit together but aren’t chemically bonded (a heterodimer). One piece, the alpha subunit, is the same one shared by LH, FSH, and TSH (three other hormones). The other piece, the beta subunit, is unique to hCG and is what gives it its specific job. That beta subunit looks a lot like the one in LH, but it has an extra tail on the end (a roughly 30-residue carboxy-terminal peptide, meaning a short string of about 30 building blocks). The whole molecule adds up to about 237 amino acids (the building blocks of proteins) and is coated in sugar chains (heavily glycosylated, ~36–37 kDa, a measure of its size). So in chemical terms it is a peptide/glycoprotein hormone — but it is not an anabolic steroid, and it is not the kind of small “research peptide” it often gets lumped in with.

Here is how it actually works. HCG acts as a stand-in for luteinizing hormone (an LH analog, or mimic). It latches onto the same docking site that LH uses — the LH/CG receptor (LHCGR), a type of cell-surface switch (a Gs-coupled GPCR) found on Leydig cells in the testes and on theca and granulosa cells in the ovary. Flipping that switch sets off a chain reaction inside the cell (it raises a messenger called cAMP, which turns on an enzyme called PKA), which then ramps up the machinery that makes sex hormones (StAR protein and enzymes like CYP11A1 and CYP17A1). The result is testosterone production in men, and support for the corpus luteum and progesterone in women. Because hCG works directly on the gonad — past the pituitary gland, rather than through it — it raises testosterone both inside the testes and in the bloodstream. At the receptor, hCG is stronger and longer-lasting than the body’s own LH.

The claims

The legitimate, FDA-approved uses are narrow: undescended testicles (prepubertal cryptorchidism) in boys, when it isn’t caused by a physical blockage; certain cases of low testosterone in men that stems from a pituitary problem (secondary, or pituitary-origin, hypogonadotropic hypogonadism); and triggering ovulation in carefully chosen infertile women who aren’t ovulating, where it is used as an “ovulation trigger” after FSH treatment as part of assisted reproduction.

The biggest popular claim — losing weight with the “hCG diet” (the Simeons protocol, which pairs a very-low-calorie diet with hCG injections) — is not an approved use, and the label flatly says so.

In the fitness world, hCG gets used off-label for a completely different reason. When people take anabolic steroids, those outside androgens shut down the body’s own hormone signaling loop (the hypothalamic-pituitary-testicular axis), which switches off LH and FSH and leads to shrinking testicles and reduced sperm production. HCG is used to poke the testes directly, trying to keep them their normal size and working, keep testosterone levels up inside the testes, and help with “restart” plans and recovering fertility. It is also used in the clinic alongside testosterone-replacement therapy (TRT) to protect fertility. The key point: hCG is not a muscle-builder on its own. Any effect it has on muscle is indirect, coming from the testosterone it nudges your body to make — and it doesn’t come close to the muscle effect of taking outside androgens.

What the evidence actually shows

Weight loss: no credible evidence. A careful review that pooled many studies (Lijesen et al., Br J Clin Pharmacol 1995; 24 trials — 8 controlled and 16 uncontrolled) found no scientific evidence that hCG helps with weight loss, shifting where fat sits, or curbing appetite and hunger beyond what cutting calories does on its own. This is what the FDA disclaimer is built on. The label states plainly that “HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY” and that there is no real evidence it boosts weight loss.

Male hypogonadotropic hypogonadism and fertility: real benefit in the right population. Gonadotropin therapy (hCG, with or without FSH/hMG) does kick-start sperm production in many men whose low hormone levels come from a gonadotropin shortage. In Liu et al. (J Clin Endocrinol Metab 2009), out of 75 such men treated, sperm showed up at a median of about 7 months and 38 men went on to father children. Three things independently predicted faster results: larger testicle size, having had gonadotropin treatment before, and never having used androgens — and adding FSH/hMG worked better than hCG alone.

TRT-adjunct fertility preservation: supported. Hsieh et al. (J Urol 2013) found that a low dose of intramuscular hCG given alongside testosterone-replacement therapy protected sperm production — no patient ended up with zero sperm (azoospermic) and their semen test results held steady — which supports using it to offset the infertility that TRT can cause.

Lean mass and strength in healthy athletes: not supported. There is no good evidence that hCG by itself adds muscle or strength in athletes whose hormone levels are already normal (eugonadal). Its job is to raise the body’s own testosterone, and that doesn’t stand in for the much bigger effect of high-dose outside androgens. Any pitch that frames hCG as a direct performance or muscle-building drug isn’t backed by the evidence.

Legal and regulatory status

In the United States, hCG is a prescription drug regulated under the Federal Food, Drug, and Cosmetic Act. It is not a controlled substance and is not scheduled under the Anabolic Steroid Control Act. (For comparison: anabolic steroids are Schedule III controlled substances; clenbuterol isn’t FDA-approved for people and isn’t scheduled; and HGH/somatropin has its own law, 21 U.S. Code § 333(e), that makes it a crime to distribute it for uses that aren’t approved — but none of those rules apply to hCG.)

Selling hCG without a valid prescription, or marketing over-the-counter or “homeopathic” hCG weight-loss drops and pills, is against the law. The FDA and FTC treat these products as illegal, fraudulent, unapproved, and mislabeled drugs, and they have sent joint warning letters to companies selling them. Having and using it with a valid prescription, though, is legal.

In sport, hCG (chorionic gonadotrophin, CG), luteinizing hormone (LH), and the substances that release them are banned under WADA Category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) — in the testosterone-stimulating-peptides subsection — at all times (both in and out of competition), and only for male athletes. (For comparison: anabolic agents sit under S1, with clenbuterol listed among “other anabolic agents,” and growth hormone is also an S2 substance.)

Safety

HCG’s safety picture is meaningfully different from that of anabolic steroids, because at its core it nudges your own body to make testosterone rather than pumping in an outside androgen. Several of the classic steroid harms just don’t come with it:

• No 17-alpha-alkylated liver damage — that liver-injury risk comes from oral alkylated steroids, which hCG is not.
• It doesn’t directly shut down your hormone loop (the HPTA) the way an outside androgen does; in fact, it’s used to counter the testicular shutdown that androgens cause. That said, by constantly driving up testosterone (some of which converts to estradiol, a form of estrogen), it can still throw off the body’s normal feedback and create its own kind of imbalance — or, with overuse, make the Leydig cells stop responding (desensitization).

Known and expected side effects include:

• Gynecomastia (breast tissue growth in men) and breast tenderness, because the extra testosterone converts to estradiol.
• Effects from higher testosterone: acne, oily skin, mood changes, fluid retention and swelling (edema), headache, and irritability; and early-onset puberty (precocious puberty) when it’s used in boys for undescended testicles — a warning that’s on the label.
• Injection-site reactions and allergic/hypersensitivity reactions (worth noting for the urine-derived protein products).
• Ovarian hyperstimulation syndrome (OHSS), where the ovaries overreact, and multiple pregnancies, when it’s used as an ovulation trigger in women — a recognized and potentially serious risk — and blood clots in arteries or veins (arterial/venous thromboembolism) have been reported when it’s used to induce ovulation.

Effects tied to higher androgen levels can also show up if testosterone climbs a lot: possible unfavorable changes in blood fats (lower HDL, the “good” cholesterol), a higher chance of thicker blood from too many red blood cells (increased hematocrit/erythrocytosis), and, in theory, added strain on the heart. These come from the resulting testosterone and estrogen levels rather than from hCG itself, and they tend to be milder than what you’d see with high-dose outside steroids. It’s worth pointing out that virilization (developing male traits), hormone-loop shutdown (HPTA suppression), and infertility are mainly concerns with outside androgens — hCG is often used precisely because it can help protect fertility and testicular function rather than suppress it — but pushing it too hard or for too long can still wear out the Leydig cells (desensitization) and knock hormones out of balance. As a general caution, hCG is not for anyone with conditions that are sensitive to androgens (such as prostate cancer), early-onset puberty, or a known allergy to it, and using it in women carries the OHSS, blood-clot, and multiple-pregnancy risks noted above. None of this is medical advice.

Bottom line

HCG is a glycoprotein gonadotropin that works as a luteinizing-hormone mimic — not a steroid and not a direct muscle-builder. The evidence splits cleanly between its real uses and its hyped ones: there’s strong human support for restarting sperm production in men short on gonadotropins and for protecting fertility during TRT, plus a formal FDA disclaimer — backed by a pooled analysis of studies — against the discredited “hCG diet.” There’s no good evidence it builds muscle or strength on its own in healthy people. In the US it’s a prescription drug, not a controlled substance, but over-the-counter weight-loss hCG is illegal and fraudulent; in sport it’s banned at all times for males.

Evidence grade: 10/10 · Established. Strong for its real endocrine indications (fertility, hypogonadism) and for the negative finding on weight loss; not supported as a standalone performance or anabolic agent.

Sources

• FDA-approved label, Pregnyl (chorionic gonadotropin) — DailyMed
• FDA-approved label PDF, Pregnyl (Organon)
• FDA — Questions and Answers on HCG Products for Weight Loss
• Lijesen GKJ, et al. The effect of hCG in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis. Br J Clin Pharmacol. 1995;40(3):237–243. PMID 8527285
• Liu PY, et al. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men. J Clin Endocrinol Metab. 2009;94(3):801–808. PMID 19066302
• Hsieh TC, et al. Concomitant intramuscular hCG preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647–650. PMID 23260550
• Casarini L, et al. Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG. Endocr Rev. 2018;39(5):549–592
• WADA 2026 Prohibited List
• USADA — 6 Things to Know About Peptide Hormones and Releasing Factors
• Cornell LII — 21 U.S. Code § 333 (Penalties; HGH subsection (e))